Vivos Therapeutics (VVOS) EPS (Basic) Growth (1y) (2021 - 2026)
Analysis
Vivos Therapeutics (VVOS) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 10.78 Bn | 9.68 Bn | 757.43 Mn | -11.79% |
| 2 | Envista Holdings | 4.18 Bn | 3.05 Bn | 407.00 Mn | 112.33% |
| 3 | Dentsply Sirona | 2.10 Bn | 1.86 Bn | 493.00 Mn | 181.65% |
| 4 | Milestone Scientific | 36.06 Mn | 33.45 Mn | 1.56 Mn | 59.47% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 19.36% |
| 6 | Vivos Therapeutics | 3.21 Mn | 1.41 Mn | 2.95 Mn | 43.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.81% |
| Mar 31, 2026 | -16.77% |
| Dec 31, 2025 | -17.77% |
| Sep 30, 2025 | -24.55% |
| Jun 30, 2025 | 7.72% |
| Mar 31, 2025 | 72.43% |
| Dec 31, 2024 | 83.71% |
| Sep 30, 2024 | 77.38% |
| Jun 30, 2024 | 87.05% |
| Mar 31, 2024 | 5.17% |
| Dec 31, 2023 | 46.67% |
| Sep 30, 2023 | 72.68% |
| Jun 30, 2023 | 43.91% |
| Mar 31, 2023 | 72.61% |
| Dec 31, 2022 | 24.01% |
| Sep 30, 2022 | 2.26% |
| Jun 30, 2022 | -68.91% |
| Mar 31, 2022 | -34.51% |
| Dec 31, 2021 | 60.80% |
| Sep 30, 2021 | -58.49% |